A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012
Clinical trial NCT06565689 · RECRUITING
Trial details
- NCT number
- NCT06565689
- Sponsor
- Excyte Biopharma Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-09
- Primary completion
- 2028-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.